Last updated 35 days ago
CLINICAL TRIAL FOR THE COMPARATIVE EVALUATION OF ACID SUPPRESSION AND SYMPTOM MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE WITH THE ADMINISTRATION OF TEGOPRAZAN OR PANTOPRAZOLE
128 patients around the world
Available in Mexico
Carnot Laboratories
2Research sites
128Patients around the world
This study is for people with
Gastrointestinal Disorders
Gastroesophageal Reflux Disease
Requirements for the patient
From 18 Years
All Gender
Medical requirements
- With endoscopic diagnosis of GERD or NERD (endoscopy ≤ 15 days old).With positive impedance pHmetry results (pHmetry ≤ 15 days old).With recurrent symptoms of heartburn and regurgitation for a previous period ≥ 3 months old.
- With known hypersensitivity to tegoprazan, pantoprazole, or any of the components of each formulation.Subjects with concomitant administration of atazanavir, nelfinavir or rilpivirine.Nephropathic and/or hepatopathic subjects (including non-alcoholic hepatitis).Subjects with upper gastrointestinal tract bleeding.Subjects with gastric and/or duodenal ulcer 2 months prior to screening.Subjects with a history of esophageal or gastric surgery.
Sites
Gastrologen
Recruiting
Clínica Saluz
Recruiting
StudyTOP-GERD
SponsorCarnot Laboratories
Study typeInterventional
Conditions
Gastroesophageal Reflux Disease
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06991348
